Feasibility of FDG PET in Inflammatory Bowel Disease

Publisher： Bentham Science Publishers

E-ISSN： 2211-5544|3|3|195-205

ISSN： 2211-5552

Source： Current Molecular Imaging, Vol.3, Iss.3, 2014-01, pp. : 195-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alicaforsen therapy in inflammatory bowel disease

By Barish Charles F  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1387-1391

Informa Healthcare

Access to resources Recommend Favorite

Depleted mucosal antioxidant defences in inflammatory bowel disease

By Buffinton G.D.   Doe W.F.  

Free Radical Biology and Medicine, Vol. 19, Iss. 6, 1995-12 ,pp. : 911-918

Elsevier

Access to resources Recommend Favorite

Interleukin-10-based therapy for inflammatory bowel disease

By Braat Henri   Peppelenbosch Maikel P   Hommes Daan W  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 5, 2003-08 ,pp. : 725-731

Informa Healthcare

Access to resources Recommend Favorite

Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease

By  

Current Protein and Peptide Science, Vol. 14, Iss. 4, 2013-06 ,pp. : 246-255

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting TNF-α for the treatment of inflammatory bowel disease

By Billiet Thomas   Rutgeerts Paul   Ferrante Marc   Van Assche Gert   Vermeire Séverine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 75-101

Informa Healthcare

Access to resources Recommend Favorite